The Monoclonal Antibodies for COVID


Monoclonal Antibodies, designed to mimic the body’s natural immune response, are

available as a treatment for COVID-19 for patients at high risk of progression to severe

disease.


There are several approved treatments for coronavirus disease 2019 (COVID-19) in

hospitalized patients but few for patients who are not sick enough to be hospitalized.

Monoclonal antibodies are a new treatment for outpatients with COVID-19 who are at

risk of progression to severe disease.


For more info check it out right here.

0 comments

© 2021 by Covid Plasma Initiative Foundation

The Yitzchok Lebovits COVID Plasma Initiative is dedicated in memory of R’ Yitzchok a"h Ben R’ Moshe Eliezer y"blt, who recently passed away. R' Yitzchok was a brother of Chaim Lebovits who has been a driving force behind every aspect of this initiative to bring this life-saving therapy to the people who need it.